Rhea J. LongleyArturo Reyes-SandovalEduardo Montoya-DíazSusanna DunachieChalermpon KumpitakWang NguitragoolIvo MuellerJetsumon SattabongkotMahidol UniversityWalter and Eliza Hall Institute of Medical ResearchUniversity of MelbourneNuffield Department of Clinical MedicineUniversity of OxfordInstituto de Salud Global de Barcelona2018-12-112019-03-142018-12-112019-03-142016-02-01Clinical and Vaccine Immunology. Vol.23, No.2 (2016), 117-1241556679X155668112-s2.0-84958629564https://repository.li.mahidol.ac.th/handle/20.500.14594/43163Copyright © 2016 American Society for Microbiology. All Rights Reserved. Plasmodium vivax is now the dominant Plasmodium species causing malaria in Thailand, yet little is known about naturally acquired immune responses to this parasite in this low-transmission region. The preerythrocytic stage of the P. vivax life cycle is considered an excellent target for a malaria vaccine, and in this study, we assessed the stability of the seropositivity and the magnitude of IgG responses to three different preerythrocytic P. vivax proteins in two groups of adults from a region of western Thailand where malaria is endemic. These individuals were enrolled in a yearlong cohort study, which comprised one group that remained P. vivax free (by quantitative PCR [qPCR] detection, no31) and another that experienced two or more blood-stage P. vivax infections during the year of follow up (no31). Despite overall low levels of seropositivity, IgG positivity and magnitude were long-lived over the 1-year period in the absence of qPCR-detectable blood-stage P. vivax infections. In contrast, in the adults with two or more P. vivax infections during the year, IgG positivity was maintained, but the magnitude of the response to P. vivax circumsporozoite protein 210 (CSP210) decreased over time. These findings demonstrate that long-term humoral immunity can develop in low-transmission regions.Mahidol UniversityBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyArticleSCOPUS10.1128/CVI.00501-15